Solara Active Pharma Sciences Ltd.
|
Ratio Analysis
|
|
You can view the
Ratio Analysis
for the last 5 years.
Market Cap. (Rs.)
|
1335.28 Cr.
|
P/BV
|
0.89
|
Book Value (Rs.)
|
416.48
|
52 Week High/Low (Rs.)
|
507/286
|
FV/ML
|
10/1
|
P/E(X)
|
0.00
|
Bookclosure
|
15/09/2023
|
EPS (Rs.)
|
0.00
|
Div Yield (%)
|
0.00
|
|
Months | 12 | 12 | 12 | 12 | 14 |
Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | |
PER SHARE RATIOS | | | | | |
| | | | | |
Basic EPS (Rs.) | -6.16 | -16.18 | 69.00 | 44.29 | 21.77 |
Diluted EPS (Rs.) | -6.16 | -16.18 | 64.53 | 42.82 | 21.73 |
Cash EPS (Rs.) | 24.70 | 15.01 | 91.87 | 77.72 | 55.29 |
Book Value[Excl.RevalReserv]/Share (Rs.) | 417.35 | 424.22 | 443.42 | 370.29 | 332.21 |
Book Value[Incl.RevalReserv]/Share (Rs.) | 417.35 | 424.22 | 443.42 | 370.29 | 332.21 |
Revenue From Operations / Share (Rs.) | 401.06 | 352.32 | 450.13 | 492.27 | 538.01 |
PBDIT / Share (Rs.) | 43.45 | 27.77 | 115.43 | 106.88 | 90.48 |
PBIT / Share (Rs.) | 12.57 | -3.42 | 85.18 | 71.81 | 58.24 |
PBT / Share (Rs.) | -12.45 | -25.31 | 61.66 | 42.80 | 26.26 |
Net Profit / Share (Rs.) | -6.18 | -16.19 | 61.62 | 42.65 | 23.06 |
NP After MI And SOA / Share (Rs.) | -6.16 | -16.15 | 61.64 | 42.69 | 23.09 |
| | | | | |
PROFITABILITY RATIOS | | | | | |
| | | | | |
PBDIT Margin (%) | 10.83 | 7.88 | 25.64 | 21.71 | 16.81 |
PBIT Margin (%) | 3.13 | -0.97 | 18.92 | 14.58 | 10.82 |
PBT Margin (%) | -3.10 | -7.18 | 13.69 | 8.69 | 4.88 |
Net Profit Margin (%) | -1.54 | -4.59 | 13.68 | 8.66 | 4.28 |
NP After MI And SOA Margin (%) | -1.53 | -4.58 | 13.69 | 8.67 | 4.29 |
Return on Networth / Equity (%) | -1.47 | -3.81 | 13.93 | 11.57 | 6.98 |
Return on Capital Employeed (%) | 2.51 | -0.65 | 16.76 | 13.54 | 11.50 |
Return On Assets (%) | -0.76 | -1.96 | 8.47 | 5.32 | 3.03 |
Long Term Debt / Equity (X) | 0.15 | 0.18 | 0.09 | 0.23 | 0.26 |
Total Debt / Equity (X) | 0.66 | 0.67 | 0.32 | 0.59 | 0.51 |
Asset Turnover Ratio (%) | 0.49 | 0.45 | 0.67 | 0.64 | 0.00 |
| | | | | |
LIQUIDITY RATIOS | | | | | |
| | | | | |
Current Ratio (X) | 1.08 | 1.16 | 1.34 | 0.92 | 0.99 |
Quick Ratio (X) | 0.57 | 0.61 | 0.96 | 0.53 | 0.66 |
Inventory Turnover Ratio (X) | 1.37 | 1.97 | 2.38 | 2.49 | 0.00 |
Dividend Payout Ratio (NP) (%) | 0.00 | -18.53 | 8.90 | 13.63 | 0.00 |
Dividend Payout Ratio (CP) (%) | 0.00 | 19.90 | 5.97 | 7.48 | 0.00 |
Earning Retention Ratio (%) | 0.00 | 118.53 | 91.10 | 86.37 | 0.00 |
Cash Earning Retention Ratio (%) | 0.00 | 80.10 | 94.03 | 92.52 | 0.00 |
| | | | | |
COVERAGE RATIOS | | | | | |
| | | | | |
Interest Coverage Ratio (%) | 1.74 | 1.33 | 4.91 | 3.68 | 2.83 |
Interest Coverage Ratio (Post Tax) (%) | 0.75 | 0.27 | 3.62 | 2.47 | 1.81 |
| | | | | |
VALUATION RATIOS | | | | | |
| | | | | |
Enterprise Value (Cr.) | 2176.74 | 3374.17 | 5329.56 | 1723.87 | 1447.40 |
EV / Net Operating Revenue (X) | 1.51 | 2.66 | 3.30 | 1.30 | 1.04 |
EV / EBITDA (X) | 13.92 | 33.74 | 12.85 | 6.01 | 6.21 |
MarketCap / Net Operating Revenue (X) | 0.81 | 1.89 | 3.10 | 0.90 | 0.77 |
Retention Ratios (%) | 0.00 | 118.53 | 91.09 | 86.36 | 0.00 |
Price / BV (X) | 0.78 | 1.57 | 3.15 | 1.20 | 1.27 |
Price / Net Operating Revenue (X) | 0.81 | 1.89 | 3.10 | 0.90 | 0.77 |
EarningsYield | -0.01 | -0.02 | 0.04 | 0.09 | 0.05 |